Epsilon Healthcare Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HDRPF research report →
About the company
Epsilon Healthcare Limited functions as a health and pharmaceuticals enterprise with core operations spanning Australia and Canada. The company's activities encompass the manufacturing and supply of hydroponic equipment, materials, and specialized nutrient solutions. Furthermore, it focuses on the development and distribution of medicinal cannabis products, alongside providing comprehensive, turnkey cultivation systems for the plant.
- CEO
- Peter Giannopoulos
- IPO
- 2018
- HQ
- Sydney, NSW, AU
Price Chart
- Market Cap
- $544.75K
- P/E
- -4.89
- P/S
- 0.62
- P/B
- 4.37
- EV/EBITDA
- -7.35
- Div Yield
- 0.00%
- Gross Margin
- 36.77%
- Op Margin
- -35.90%
- Net Margin
- -12.99%
- ROE
- -65.59%
- ROIC
- -17.32%
- Revenue
- $9.39M · 67.67%
- Net Income
- $-2,049,851 · -2.06%
- EPS
- $-0.01 · 0.00%
- Op Income
- $-2,376,452
- FCF YoY
- 5.94%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.75
- Avg Volume
- 5.12K
Get TickerSpark's AI analysis on HDRPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our HDRPF coverage
Recent articles, reports, and earnings notes.
No research on HDRPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HDRPF report →Similar companies
Peers in the same neighborhood.